Qualigen Therapeutics Quote - QLGN

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.39

Bid

3.25

Ask

3.99

Volume

100

0.00 Day's Range 0.00

2.96 52 Week Range 29.435

Market Cap

2.497M

Previous Close

3.50

Open

Last Trade

100

3.39

(formt)

Last Trade Time

03:12:36

Financial Volume

VWAP

Average Volume (3m)

70,655

Shares Outstanding

736,431

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-18.22

Revenue

Net Profit

-13.42M

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.qualigeninc.com

Headquarters

Wilmington, Delaware, USA

Founded

Qualigen Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QLGN. The last closing price for Qualigen Therapeutics was US$3.50. Over the last year, Qualigen Therapeutics shares have traded in a share price range of US$ 2.96 to US$ 29.435.

Qualigen Therapeutics currently has 736,431 shares outstanding. The market capitalization of Qualigen Therapeutics is US$2.58 million. Qualigen Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

Form 8-K - Current report

Qualigen to participate in next funding round for NanoSynex

Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the...

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.65	-16.0891089109	4.04	4.04	2.96	295951	3.17687208	CS
4	-1.26	-27.0967741935	4.65	4.6585	2.96	118862	3.41386275	CS
12	-0.94	-21.7090069284	4.33	5.046	2.96	70655	3.81914716	CS
26	-6.21	-64.6875	9.6	11.5	2.96	1520109	5.95475293	CS
52	-20.95	-86.0723089565	24.34	29.435	2.96	3980719	15.50024258	CS
156	-420.31	-99.1999055936	423.7	760	2.96	1504457	48.92310434	CS
260	-3621.61	-99.9064827586	3625	3950	2.96	1772000	661.77071184	CS

QLGN - Frequently Asked Questions (FAQ)

What is the current Qualigen Therapeutics share price?

The current share price of Qualigen Therapeutics is US$ 3.39

How many Qualigen Therapeutics shares are in issue?

Qualigen Therapeutics has 736,431 shares in issue

What is the market cap of Qualigen Therapeutics?

The market capitalisation of Qualigen Therapeutics is USD 2.58M

What is the 1 year trading range for Qualigen Therapeutics share price?

Qualigen Therapeutics has traded in the range of US$ 2.96 to US$ 29.435 during the past year

What is the PE ratio of Qualigen Therapeutics?

The price to earnings ratio of Qualigen Therapeutics is -0.02

What is the reporting currency for Qualigen Therapeutics?

Qualigen Therapeutics reports financial results in USD

What is the latest annual profit for Qualigen Therapeutics?

The latest annual profit of Qualigen Therapeutics is USD -13.42M

What is the registered address of Qualigen Therapeutics?

The registered address for Qualigen Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Qualigen Therapeutics website address?

The website address for Qualigen Therapeutics is www.qualigeninc.com

Which industry sector does Qualigen Therapeutics operate in?

Qualigen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EVAXEvaxion Biotech AS	US$ 4.45 (85.42%)	8.62M
TNFATNF Pharmaceuticals Inc	US$ 0.98 (34.62%)	100
PLTUDirexion DAily PLTR Bull 2X Shares	US$ 43.70 (32.46%)	82.02k
PTIRGraniteShares 2X Long PLTR Daily ETF	US$ 205.20 (32.12%)	56.12k
IVVDInvivyd Inc	US$ 1.36 (28.30%)	8.86M
UPCUniverse Pharmaceuticals Inc	US$ 0.3007 (-27.96%)	44.9k
UOKAMDJM Ltd	US$ 0.1731 (-27.27%)	542.63k
BCTXBriaCell Therapeutics Corporation	US$ 3.67 (-27.18%)	16.79k
EJHE Home Household Service Holdings Ltd	US$ 0.7652 (-24.98%)	35.37k
TENXTenax Therapeutics Inc	US$ 4.48 (-24.71%)	98
IVVDInvivyd Inc	US$ 1.36 (28.30%)	8.86M
EVAXEvaxion Biotech AS	US$ 4.45 (85.42%)	8.62M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0405 (-12.34%)	2.34M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.163 (-16.37%)	2.24M
RIMEAlgorhythm Holdings Inc	US$ 0.0268 (0.37%)	1.78M